Hello, my name is Dieter Plas and I run a Belgian-based consultancy and coaching firm specialized in giving training and guidance to investors during their journey on the financial markets. We are best at writing crystal clear analysis and providing clear and understandable investment advise for our customers.
We are specialized in European markets and European shares.
Contact us via: email@example.com
I invest in the Graham and Buffett tradition, looking for significant discrepancies between price and value, with catalysts to help recognize value. I also apply value investing principles to the biopharmaceutical sector, where I aim to find highly asymmetric bets to include as a portion of a balanced portfolio. My Guiding Principle #1: "Heads I Win, Tails I Don't Lose Much" My Rule #1: "Don't Lose Money".
MD, MBA (NYU-Stern, Finance specialization). Founder: Vasuda Healthcare Analytics, premium research service covering emerging biotech/ pharma companies (in partnership with Seeking Alpha). Licensed Investment Advisor. Ranked 5-star analyst on Tipranks.
Buy-side equity research analyst covering mainly small-cap, emerging pharma/ biotech companies. M.D. with over 18 years of clinical experience (in the U.S. and India), still retaining full medical license in India. M.B.A. with finance and financial markets specialization from New York University Stern School of Business.
Expert in picking healthcare-related investments, especially biotechnology and pharmaceuticals (focus on small, emerging companies). Investments are selected based on detailed due diligence, including proprietary DCF valuation models. Value investor with long-term horizon.
Founder, managing principal of Vasuda Capital Management, healthcare focused investment management firm, vasudacapitalmanagement.com. Registered Investment Advisor in Massachusetts. The firm also operates a private pooled investment partnership, Vasuda Life Sciences Fund.
Also started and continue to sponsor Vasuda Global Orphan/ Rare disease biotechnology index, the first global equity index covering rare/orphan disease sector. Index quotes are available on bloomberg/reuters terminals.
Value investor focused on micro-caps.
I write for CompleteBankData and am also a
Passively looking for a job on the buyside.
Always looking for more opportunities and to grow my professional network. Feel free to message me anytime.
Disclaimer: Nick reminds investors to always due their own due diligence on any investment, and to consult their own financial adviser or representative when necessary. Any material provided is intended as general information only, and should not be considered or relied upon as a formal investment recommendation
I am a graduate in Finance, currently working as a portfolio manager. However, foremost, I am an investor! My strategy is twofold and aims primarily at value stocks. I like Joel Greenblatt's magic formula as a general starting point, but many companies in there can be tricky stocks, so I perform extensive qualitative and quantitative analysis to pick the best ones. My articles represent (parts of) this analysis and I always like to discuss different standpoints on stocks like these. A second strategic focus is dividend growth investing, as I believe it to provide the steadiest stream of income for retirement over time. My main problem with it is that companies with an increasing and attractive dividend are not often undervalued. Consequently, I perform less transactions in this area. However, sometimes the market just blurts out a gem cheaply, and I can simply not resist (for example PM < $80, RDS.A < 20). If you have any questions, suggestions or comments, please feel free to contact me.
The Investing Dutchman
David Chopin is a freshman at the University of Missouri - Columbia and the founder of Student Investing Guide, a website dedicated to educating college students about the importance and how-to of investing at an early age. David has been investing for 3 years and hopes to pursue a career in financial analysis and ultimately portfolio management. His investing style could be described primarily as value/deep value/contrarian, but he believes that any company can present a good investment opportunity at the right price. David is also pursuing internship opportunities that involve security analysis/the formation of investment theses.
It's been quite a journey the past five years as I've learned about stocks, technical analysis, swing trading, dividend growth investing, and now options. For 17 years, I home educated our children and tutored, while my husband supported the family. Once I worked myself out of that job, I had to decide what I should be when I grow up. Without a useful degree, my income is minimal, but I really enjoy my part-time jobs. I have used my jobs as a learning tool more than an income tool and they have been very profitable. I focus the rest of my time making my husband's income the most useful it can be, and managing our home. I enjoy playing with bookkeeping, finance, investments, taxes, and strive to be the best steward of all the resources (time, energy, health, family, money, stuff) we have. The only purpose of my investing was to be able to afford to retire at a normal, reasonable age and hopefully to live off the dividends from those investments without needing to spend down the principal. As health concerns are forcing us to consider earlier retirement, the portfolio income may be needed at anytime. This does not worry me, it just changes the trajectory of the portfolio. I am very thankful for the gentle start into investing and am excited by what might happen in the future. I’m so glad this website was recommended to me and I genuinely appreciate the contributors and their comments here and the growth that has happened through participation on the forum. In case you're wondering about 'inzkeeper', I formerly managed an inn and the email moniker has stuck with me over the years.
Brian Harper, CFA is Chief Investment Officer of Harper Asset Management, LLC, which he founded in 2001. Harper Asset Management is a value-oriented investment manager, primarily managing separate accounts for high net worth individuals. Visit us at www.harperasset.com.
Harper Asset Mgmt operates a bottom-up, fundamental, research intensive approach to investing. We focus primarily on value, special-situation, and micro-cap issues.
I am an individual Value investor, and started my investing journey in 2013. With an engineering background (Bachelors Degree in Mechanical Engineering, McMaster University), I understand and have an interest in business and operations, and take the classic Buffett/Graham view that my investments are in pieces of a business. My focus is on long ideas with a contrarian and deep value spin. I tend to focus on the numbers and financials, avoiding speculation and unfounded claims. I follow such greats as Graham, Greenblatt, Schloss, Klarman, Greenwald, and newer players such as Carlisle and Grey.
Investment Manager at Rugged Group LLC, an independent, fee-only registered investment advisor based in New York that I formed in August 2015. My firm's investment approach can be summarized in the same four, one-syllable words that Walter Schloss famously used: We Buy Cheap Stocks. Alternatively, you could say I am a quantitative deep value investor. I also invest globally, scouring many markets in search of cheap stocks.
Website | Email | LinkedIn | Twitter | Harvest
Looking for blatant mispricing typically under $1bn market cap -- in either direction, with a short bias. L/S equity fund analyst. Passed all levels of the CFA program; MBA in finance from a top-5 school.
Amvona publishes critical articles on Faith, Investing, Economics and Technology.
The Finding Alpha category of Amvona profiles investments made, including case studies, economic discussion and explanations of the investment rationales.
more at: http://www.amvona.com/about-us
Oliver is principal at Huckleberry Investments, a London based investment manager. He invests using a long-term value strategy, aiming to produce low-risk returns far in excess of the market. Oliver achieves this outcome by running a very concentrated portfolio, relying on intensive research to uncover the best opportunities. At Huckleberry, volatility is often elevated, but fear of volatility should never get in the way of low-risk returns. Single name short positions are very rare and are only initiated if conviction is high.
Sirius Capital is a Biotech Portfolio Management firm specializing in mid term investments in clinical stage biotech and pharma companies.
Our analysts combine their extensive experience in Pharma and drug development with financial management expertise to yield maximal profit to our clients.
I'm retired from a near 40 year career in the publishing industry working with an international publishing company. My investing experience is over a span of 40 years. Luckily with more winners than losers! My hobbies are world travel, reading good books(non-fiction)--and researching stocks that I have an interest. In my retirement, I volunteer my time working in assisting several lawyers with their Child Protective Service cases.(Drugs are destroying our Society and family structure) I also serve as a reviewer for a national literary prize given each year.
Senior at Grove City College. Searching for material price / value dislocations in high-quality businesses.
I use this to gather feedback on my research and as a means of monetizing the work I am doing anyway. May or may not have positions in stocks mentioned.
Feel free to reach out.
Jonathan co-founded Booth-Laird Enterprises, LLC in 2007 and serves as the company’s chief executive officer. He is primarily responsible for structuring and overseeing the company’s vision of wealth creation via value-decision making, setting an appropriate culture, and overseeing the company’s investments.
Jonathan is a Chartered Financial Analyst and a Certified Public Accountant. He was awarded the 2006 Elijah Watt Sells award for scoring one of the 10 highest scores in the nation on the 2006 CPA exam. He also passed all three levels of the CFA exam on his first attempt. In addition, he was awarded the 2008 “Top 40 Under Forty” award from the Greater Baton Rouge Business Report, which is given annually to the forty men and women under the age of forty who have earned the most personal and professional achievements or made the most significant impact in the Greater Baton Rouge area.
He worked for three years as an auditor with Ernst & Young, LLP and KPMG, LLP, two of the four largest accounting firms in the world. At both firms, he was rated “exceptional performer” every year and was entrusted with responsibilities above his level within months of starting with each firm. He audited both public and private companies in a variety of industries, including acting as the lead audit senior on a Fortune 500 company. He was regularly assigned the most complex accounting issues and the most challenging audit areas. As a result of his experience, he has developed an astute understanding of risk management, team management, optimal business processes, effective corporate governance practices, and various industries and business models.
While at KPMG, he served as the only South Louisiana member on the KPMG Point-of-View group, an internal group of highly rated employees across the United States focused on strategic initiatives and determining best practices.
Subsequent to KPMG, he worked for a year in Governor Bobby Jindal’s administration as the Assistant Director of State Economic Competitiveness, a subgroup of the Department of Economic Development charged with helping to shape the State’s economic policy in addition to various other tasks. Among a number of other significant projects, he helped craft the department-wide business plan for Fiscal Year 2009-2010, which further developed his strategic planning capabilities. He also met with representatives of the business community to help resolve issues or to hear proposals, which gave him further insight into various industries and business models.
Jonathan earned a bachelor’s of science in accounting from Louisiana State University, graduating summa cum laude, and earned a master of science in accounting from Louisiana State University, graduating top of his class with a perfect 4.0 GPA.